Literature DB >> 1454342

Retinal pigment epitheliopathy after macular hole surgery.

L S Poliner1, P E Tornambe.   

Abstract

BACKGROUND: Full-thickness idiopathic macular holes were previously considered untreatable, but surgical intervention has been proposed to collapse the hole and improve vision. This study evaluates the fluorescein angiographic changes that occur after macular hole surgery.
METHODS: Sixteen patients with stage III idiopathic macular holes underwent pars plana vitrectomy, removal of the posterior hyaloid, peeling of fine epiretinal sheets along the edges of the holes, and fluid-gas exchange. Preoperative fluorescein angiograms were performed, and best-corrected preoperative visual acuity was 20/200 or less in all eyes.
RESULTS: Postoperatively, the macular hole disappeared in 12 eyes (75%). In all 12 eyes, retinal pigment epithelial swelling was present, with a unique fluorescein angiographic appearance. This pattern slowly resolved over months, with gradual visual improvement but residual retinal pigment epithelial mottling. Systemic and periocular steroids had no significant impact on the process.
CONCLUSION: The combination of prolonged intraocular gas contact and light exposure exceeding threshold for an already compromised macula appears to be responsible for this pigmentary pattern. Depending on the severity of the pigment epithelial alteration, this unique pattern may portend a guarded visual prognosis in affected patients undergoing successful macular hole repair.

Entities:  

Mesh:

Year:  1992        PMID: 1454342     DOI: 10.1016/s0161-6420(92)31746-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Endoillumination during vitrectomy and phototoxicity thresholds.

Authors:  P R van den Biesen; T Berenschot; R M Verdaasdonk; H van Weelden; D van Norren
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Macular hole and myopic refraction.

Authors:  H Kobayashi; K Kobayashi; S Okinami
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

3.  Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery.

Authors:  Aude Husson-Danan; Agnès Glacet-Bernard; Gisèle Soubrane; Gabriel Coscas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03       Impact factor: 3.117

4.  Late reopening of successfully treated macular holes.

Authors:  M Paques; P Massin; P Y Santiago; A C Spielmann; J F Le Gargasson; A Gaudric
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

5.  Macular pigment levels following successful macular hole surgery.

Authors:  K Neelam; N O'Gorman; J Nolan; O O'Donovan; K G Au Eong; S Beatty
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

6.  Peripheral visual field loss after vitreous surgery for macular holes.

Authors:  S Bopp; K Lucke; U Hille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 7.  The susceptibility of the retina to photochemical damage from visible light.

Authors:  Jennifer J Hunter; Jessica I W Morgan; William H Merigan; David H Sliney; Janet R Sparrow; David R Williams
Journal:  Prog Retin Eye Res       Date:  2011-11-10       Impact factor: 21.198

8.  Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole.

Authors:  T S Chang; E McGill; D A Hay; W H Ross; A L Maberley; L M Sibley; P E Ma; M J Potter
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

9.  Combined pars plana lensectomy/vitrectomy for idiopathic macular hole repair without postoperative prone positioning.

Authors:  Nicola G Ghazi; Armand Daccache; Robert Knape; James S Tiedeman
Journal:  Digit J Ophthalmol       Date:  2008-11-24

10.  Two cases of severe degeneration of the macula following vitrectomy with indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole.

Authors:  Junji Inoue; Toshiro Sakuma; Masatoshi Kiyokawa; Yasuhiko Kobayashi; Hiroshi Takebayashi; Atsushi Mizota; Minoru Tanaka
Journal:  Open Ophthalmol J       Date:  2008-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.